|
Market Closed -
Euronext Dublin
19:55:00 01/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.000 EUR | 0.00% |
|
0.00% | -9.09% |
| 08-26 | Malin swings to interim profit as finance income rises and costs fall | AN |
| 02-26 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| Market Cap | 30.35M 34.17M 28.38M 25.86M 48.69M 3.29B 49.36M 343M 133M 1.68B 128M 125M 5.38B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 17.45M 19.64M 16.31M 14.87M 27.99M 1.89B 28.37M 197M 76.4M 963M 73.74M 72.15M 3.09B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 3 months | -6.04% | ||
| 6 months | -9.09% | ||
| Current year | -9.09% |
| 1 week | 7 |  | 7 |
| 1 month | 6.8 | | 7 |
| Current year | 6.8 | | 8.45 |
| 1 year | 6.8 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 13.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 01/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 02/08/2019 |
| Director/Board Member | 67 | 16/07/2018 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 16/07/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/06/26 | Exercice | 10,307 | 0.2382% | |||
| 28/05/25 | Exercice | Chief Executive Officer | 5,746 | 0.1328% | ||
| 07/04/25 | Sell | Director | 11,075 | 0.2560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -14.63% | +54.19% | 34.46M | |
| -0.62% | -0.10% | +50.70% | +114.07% | 1,031B | |
| -2.30% | -3.90% | +39.50% | +66.07% | 638B | |
| -0.63% | -1.94% | +12.26% | +74.38% | 462B | |
| -1.03% | -2.88% | +71.35% | +39.69% | 359B | |
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | |
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | |
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | |
| -3.38% | +0.29% | +44.32% | +51.54% | 228B | |
| -1.04% | -2.56% | +32.88% | +96.82% | 185B | |
| Average | -1.16% | -0.33% | +29.62% | +57.03% | 376.39B | |
| Weighted average by Cap. | -1.02% | -0.35% | +38.05% | +69.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -7.77M -6.45M -5.88M -11.07M -748M -11.22M -78.06M -30.22M -381M -29.17M -28.53M -1.22B |
| Net Debt | -62.1M -69.92M -58.07M -52.92M -99.63M -6.73B -101M -703M -272M -3.43B -263M -257M -11.01B | -12.9M -14.52M -12.06M -10.99M -20.7M -1.4B -20.98M -146M -56.5M -712M -54.53M -53.35M -2.29B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | €7.000 | 0.00% | 0 |
| 30/09/26 | €7.000 | 0.00% | 0 |
| 29/09/26 | €7.000 | 0.00% | 73 |
| 28/09/26 | €7.000 | 0.00% | 0 |
| 25/09/26 | €7.000 | 0.00% | 0 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.000EUR
Average target price
15.50EUR
Spread / Average Target
+121.43%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
